Pages

.

Showing posts with label Senior. Show all posts
Showing posts with label Senior. Show all posts

Stephen Ritter Joins Emotient as Senior Vice President of Product Development

SAN DIEGO, June 19, 2014 /PRNewswire/ -- Emotient, the leading provider of facial expression analysis software, today announced that Stephen Ritter joined the company as Senior Vice President of Product Development. Stephen brings extensive engineering management experience from successful start-ups and larger enterprises, including Cypher Genomics, Websense and McAfee, an Intel company.

"Steve is a proven technology leader who has demonstrated success in transforming cutting edge technology into highly successful commercial products," said Ken Denman, President and CEO, Emotient. "We will rely on his expertise as we continue to drive our innovative, emotion-aware software into the healthcare and retail markets, through a cloud-based platform."

"Emotient is at the forefront of a massive trend in emotion-aware computing," said Ritter.  "Emotient's founding team is spearheading the development of proprietary technology that sets the industry standard for accuracy and real-time delivery of facial expression data and analysis. I look forward to leading the commercial delivery of new emotion analytics products for retail and healthcare based on our state-of-the-art technology."

Most recently, Stephen served as CTO at Cypher Genomics, a leading genome informatics company. Previously, he was Vice President, Engineering for Websense, where he led a global team in the development of the market leading web security product, TRITON Web Security Gateway. Prior to WebSense he served as senior director of engineering at McAfee, now an Intel company, where he developed one of the most advanced and scalable security management software systems in the industry.

Ritter began his career as an accomplished software developer/architect and currently holds six patents in the area of information security. He holds a B.S. in Cognitive Science from UC San Diego.

About Emotient – Emotion Recognition Technology (www.emotient.com)
Emotient, Inc., is the leading authority in facial expression analysis. Emotient's software translates facial expressions into actionable information, thereby enabling companies to develop emotion-aware technologies and to create new levels of customer engagement, research, and analysis. Emotient's facial expression technology is currently available to Global 2000 companies within the retail, healthcare and consumer packaged goods industries.

Emotient was founded by a team of six Ph.D.s from the University of California, San Diego, who are the foremost experts in applying machine learning, computer vision and cognitive neuroscience to facial behavioral analysis.

SOURCE Emotient

RELATED LINKS
http://www.emotient.com

reade more... Résuméabuiyad

Chiltern Appoints Dr. Michael Wisniewski As Senior Executive Director, Biometrics

LONDON, and WILMINGTON, N.C., May 28, 2014 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), today announced the appointment of Michael Wisniewski, PhD as Sr. Executive Director, Biometrics to lead Chiltern's global Biostatistics team and provide expertise and consultancy to Chiltern clients.

Alecia Barbee, Chiltern's Vice President, Global Biometrics offered: "We are very excited to have Dr. Wisniewski join Chiltern to oversee our global Biostatistics and Statistical Programming groups. Michael brings an outstanding mix of Pharma, CRO, and academia experiences that will help Chiltern continue to advance our industry-leading biometrics service offerings."

With 30 years industry experience, Dr. Wisniewski joins Chiltern as a leader in product development, including over 23 years at Glaxo SmithKline as Executive Director of Clinical Statistics and Programming.  He is widely published in oncology and respiratory topics and has been involved in 11 regulatory submissions to FDA and other agencies leading to marketing approval.

Company profile

About Chiltern:
Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs more than 1,600 people globally and offers services in Global Clinical Development, Global Scientific Services, and Global Resourcing Solutions. Chiltern prides itself as a development partner that offers innovation, responsiveness and quality delivery.

Further information is available at: www.chiltern.com.

For more information contact:
Nicholas Spittal
Sr. Director, Global Commercial Affairs
Chiltern International Inc.
2528 Independence Blvd. Suite 101
Wilmington, NC 28412
USA
Tel:  +1 (910) 338 4760
Email: global.marketing@chiltern.com

SOURCE Chiltern

RELATED LINKS
http://www.chiltern.com

reade more... Résuméabuiyad